Public Profile

Northwest Biotherapeutics, Inc.

Northwest Biotherapeutics, Inc. (often referred to as NW Bio) is a pioneering biotechnology company headquartered in the United States, with significant operational activities in the field of cancer immunotherapy. Founded in 2001, the company has made notable strides in developing innovative therapies, particularly its lead product, DCVax®-L, which is designed to treat various types of cancer by harnessing the body’s immune system. With a focus on personalised medicine, Northwest Biotherapeutics stands out in the biopharmaceutical industry for its unique approach to dendritic cell therapy. The company has achieved key milestones, including successful clinical trials that underscore its commitment to advancing cancer treatment. As a leader in the immunotherapy sector, NW Bio continues to position itself at the forefront of cancer research, aiming to improve patient outcomes and redefine therapeutic standards.

DitchCarbon Score

How does Northwest Biotherapeutics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

18

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

2

Industry Benchmark

Northwest Biotherapeutics, Inc.'s score of 18 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.

22%

Let us know if this data was useful to you

Northwest Biotherapeutics, Inc.'s reported carbon emissions

Northwest Biotherapeutics, Inc., headquartered in the US, currently does not have any publicly available carbon emissions data for the most recent year, nor do they have specified reduction targets or climate pledges. This absence of data suggests that the company may not have established formal commitments to reduce carbon emissions or may not have disclosed such information. In the context of the biotherapeutics industry, many companies are increasingly focusing on sustainability and climate action, but specific initiatives or targets from Northwest Biotherapeutics remain unclear. As the industry evolves, it will be important for the company to consider implementing measurable climate commitments to align with broader environmental goals.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Northwest Biotherapeutics, Inc.'s primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Northwest Biotherapeutics, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Northwest Biotherapeutics, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

ViewRay, Inc.

US
Medical, precision and optical instruments, watches and clocks (33)
Updated 12 days ago

Plus Therapeutics, Inc.

US
Health and social work services (85)
Updated 4 days ago

FATE

HU
Wood and products of wood and cork (except furniture); articles of straw and plaiting materials (20)
Updated 12 days ago

Perspective Therapeutics, Inc.

US
Health and social work services (85)
Updated 12 days ago

AVEO Pharmaceuticals, Inc.

US
Health and social work services (85)
Updated 4 months ago
DitchCarbon Score

Cyclacel Pharmaceuticals, Inc.

US
Health and social work services (85)
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers